Telemetry Investments, L.L.C. - Q4 2018 holdings

$157 Million is the total value of Telemetry Investments, L.L.C.'s 136 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was - .

 Value Shares↓ Weighting
XPO NewXPO LOGISTICS INCcall$5,681,00099,600
+100.0%
3.62%
XLF NewSELECT SECTOR SPDR TRsbi int-finl$4,168,000175,000
+100.0%
2.66%
RHT NewRED HAT INC$2,493,00014,195
+100.0%
1.59%
SCG NewSCANA CORP NEW$1,677,00035,100
+100.0%
1.07%
NewVERASTEM INCnote 5.000%11/0$1,560,0002,000,000
+100.0%
0.99%
JPM NewJPMORGAN CHASE & CO$1,542,00015,800
+100.0%
0.98%
GOOG NewALPHABET INCcap stk cl c$1,346,0001,300
+100.0%
0.86%
XHB NewSPDR SERIES TRUSTcall$1,301,00040,000
+100.0%
0.83%
CHRW NewC H ROBINSON WORLDWIDE INCput$1,261,00015,000
+100.0%
0.80%
NewCLOVIS ONCOLOGY INCnote 2.500% 9/1$1,252,0001,500,000
+100.0%
0.80%
NewINSMED INCnote 1.750% 1/1$1,246,0001,750,000
+100.0%
0.79%
BAC NewBANK AMER CORPcall$1,232,00050,000
+100.0%
0.78%
TSRO NewTESARO INC$1,077,00014,500
+100.0%
0.69%
FDX NewFEDEX CORP$1,028,0006,370
+100.0%
0.66%
EWW NewISHARES INCmsci mexico etf$988,00024,000
+100.0%
0.63%
JNJ NewJOHNSON & JOHNSON$883,0006,845
+100.0%
0.56%
VLP NewVALERO ENERGY PARTNERS LP$822,00019,500
+100.0%
0.52%
DIS NewDISNEY WALT CO$822,0007,500
+100.0%
0.52%
XOM NewEXXON MOBIL CORP$733,00010,755
+100.0%
0.47%
NFX NewNEWFIELD EXPL CO$594,00040,500
+100.0%
0.38%
ATHN NewATHENAHEALTH INC$528,0004,000
+100.0%
0.34%
ITG NewINVESTMENT TECHNOLOGY GRP NE$499,00016,500
+100.0%
0.32%
CRVS NewCORVUS PHARMACEUTICALS INC$496,000135,123
+100.0%
0.32%
RCKT NewROCKET PHARMACEUTICALS INC$489,00033,000
+100.0%
0.31%
XHB NewSPDR SERIES TRUSTs&p homebuild$488,00015,000
+100.0%
0.31%
EWZ NewISHARES INCmsci brazil etf$458,00012,000
+100.0%
0.29%
CI NewCIGNA CORP NEW$433,0002,281
+100.0%
0.28%
DNB NewDUN & BRADSTREET CORP DEL NE$428,0003,000
+100.0%
0.27%
STML NewSTEMLINE THERAPEUTICS INC$395,00041,588
+100.0%
0.25%
USG NewU S G CORP$378,0008,854
+100.0%
0.24%
ESL NewESTERLINE TECHNOLOGIES CORP$364,0003,000
+100.0%
0.23%
S NewSPRINT CORP$357,00061,397
+100.0%
0.23%
AMRN NewAMARIN CORP PLCcall$354,00026,000
+100.0%
0.23%
P NewPANDORA MEDIA INC$344,00042,500
+100.0%
0.22%
HIFR NewINFRAREIT INC$326,00015,500
+100.0%
0.21%
CVS NewCVS HEALTH CORP$303,0004,620
+100.0%
0.19%
BHC NewBAUSCH HEALTH COS INCput$277,00015,000
+100.0%
0.18%
NFLX NewNETFLIX INC$268,0001,000
+100.0%
0.17%
MPC NewMARATHON PETE CORP$264,0004,472
+100.0%
0.17%
QQQ NewINVESCO QQQ TRunit ser 1$262,0001,700
+100.0%
0.17%
ENB NewENBRIDGE INC$253,0008,152
+100.0%
0.16%
INTC NewINTEL CORP$249,0005,300
+100.0%
0.16%
UTX NewUNITED TECHNOLOGIES CORP$232,0002,175
+100.0%
0.15%
MSFT NewMICROSOFT CORP$223,0002,200
+100.0%
0.14%
NAVG NewNAVIGATORS GROUP INC$208,0003,000
+100.0%
0.13%
NXEO NewNEXEO SOLUTIONS INC$209,00024,300
+100.0%
0.13%
VSTM NewVERASTEM INCcall$168,00050,000
+100.0%
0.11%
SENS NewSENSEONICS HLDGS INC$151,00058,463
+100.0%
0.10%
PACB NewPACIFIC BIOSCIENCES CALIF IN$148,00020,000
+100.0%
0.09%
PRTK NewPARATEK PHARMACEUTICALS INC$113,00022,000
+100.0%
0.07%
NIHD NewNII HLDGS INC$110,00025,000
+100.0%
0.07%
ELGX NewENDOLOGIX INC$79,000110,000
+100.0%
0.05%
INTX NewINTERSECTIONS INC$48,00013,000
+100.0%
0.03%
BBOX NewBLACK BOX CORP DEL$47,00043,128
+100.0%
0.03%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
RIGEL PHARMACEUTICALS INC33Q4 20221.7%
AFFIMED N V31Q4 20223.9%
GLOBALSTAR INC30Q4 20222.5%
VIEWRAY INC23Q4 20222.1%
SPDR GOLD TRUST22Q4 20222.3%
ADMA BIOLOGICS INC21Q4 20222.9%
STEMLINE THERAPEUTICS INC21Q1 20201.2%
SPDR S&P 500 ETF TR20Q4 202253.9%
KADMON HLDGS INC19Q2 20217.0%
EIGER BIOPHARMACEUTICALS INC19Q4 20226.7%

View Telemetry Investments, L.L.C.'s complete holdings history.

Latest significant ownerships (13-D/G)
Telemetry Investments, L.L.C. Q4 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Xtant Medical Holdings, Inc.February 13, 2020752,9155.7%
Orexigen Therapeutics, Inc.February 14, 20191,295,8446.4%
Xtant Medical Holdings, Inc.February 14, 20181,416,3397.2%

View Telemetry Investments, L.L.C.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2023-02-14
13F-HR2022-11-17
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15
13F-HR2021-08-16
13F-HR2021-05-17
13F-HR2021-02-16
13F-HR2020-11-16

View Telemetry Investments, L.L.C.'s complete filings history.

Compare quarters

Export Telemetry Investments, L.L.C.'s holdings